Morgan Stanley article:
All told, general concerns about an economic slowdown, as well as market fears more specifically pegged to the Delta variant, seem largely unwarranted—as does investors’ persistent push into supposedly defensive trades that favor mega-cap tech stocks. Indeed, the cyclical recovery still has more room left to play out in services, bank lending, inventory restocking and global trade. Investors should consider deploying cash into cyclicals, small- and mid-cap stocks, as well as non-U.S. developed-market stocks, as they look ahead to above-average economic growth in 2022. Emerging markets may also make sense for patient, long-term investors.